The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Drugs of Abuse Analysis Controls market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Drugs of Abuse Analysis Controls is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Drugs of Abuse Analysis Controls is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Drugs of Abuse Analysis Controls include Siemens, Abbott, QuidelOrtho Corporation, Thermo Fisher Scientific, Horiba, Beckman Coulter, Ortho Clinical Diagnostics, Microgenics and MedTest DX, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Drugs of Abuse Analysis Controls in Hospital is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Liquid, which accounted for % of the global market of Drugs of Abuse Analysis Controls in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs of Abuse Analysis Controls, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs of Abuse Analysis Controls.
The Drugs of Abuse Analysis Controls market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drugs of Abuse Analysis Controls market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs of Abuse Analysis Controls manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Siemens
- Abbott
- Quidelortho Corporation
- Thermo Fisher Scientific
- Horiba
- Beckman Coulter
- Ortho Clinical Diagnostics
- Microgenics
- Medtest Dx
- Carolina Liquid Chemistries
- Cerilliant
- American Bio Medica Corp
- Clarity Diagnostics Llc
- Diatron
- Kova International
- Lin-Zhi International Inc
- Jas Diagnostics
- Quasar Instruments
- Btnx
- Bio-Rad Laboratories
Product Type Insights
Global markets are presented by Drugs of Abuse Analysis Controls type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Drugs of Abuse Analysis Controls are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Drugs of Abuse Analysis Controls segment by Type
- Liquid
- Lyophilized
- Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Drugs of Abuse Analysis Controls market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drugs of Abuse Analysis Controls market.
Drugs of Abuse Analysis Controls segment by Application
- Hospital
- Clinical
- Diagnostic Laboratories
- Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drugs of Abuse Analysis Controls market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs of Abuse Analysis Controls market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Drugs of Abuse Analysis Controls and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drugs of Abuse Analysis Controls industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs of Abuse Analysis Controls.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drugs of Abuse Analysis Controls manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drugs of Abuse Analysis Controls in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index
1 Drugs of Abuse Analysis Controls Market Overview
1.1 Product Overview and Scope of Drugs of Abuse Analysis Controls
1.2 Drugs of Abuse Analysis Controls Segment by Type
1.2.1 Global Drugs of Abuse Analysis Controls Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Liquid
1.2.3 Lyophilized
1.2.4 Others
1.3 Drugs of Abuse Analysis Controls Segment by Application
1.3.1 Global Drugs of Abuse Analysis Controls Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinical
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Global Drugs of Abuse Analysis Controls Market Size Estimates and Forecasts
1.4.1 Global Drugs of Abuse Analysis Controls Revenue 2017-2028
1.4.2 Global Drugs of Abuse Analysis Controls Sales 2017-2028
1.4.3 Drugs of Abuse Analysis Controls Market Size by Region: 2017 Versus 2021 Versus 2028
2 Drugs of Abuse Analysis Controls Market Competition by Manufacturers
2.1 Global Drugs of Abuse Analysis Controls Sales Market Share by Manufacturers (2017-2022)
2.2 Global Drugs of Abuse Analysis Controls Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Drugs of Abuse Analysis Controls Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Drugs of Abuse Analysis Controls Manufacturing Sites, Area Served, Product Type
2.5 Drugs of Abuse Analysis Controls Market Competitive Situation and Trends
2.5.1 Drugs of Abuse Analysis Controls Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drugs of Abuse Analysis Controls Players Market Share by Revenue
2.5.3 Global Drugs of Abuse Analysis Controls Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drugs of Abuse Analysis Controls Retrospective Market Scenario by Region
3.1 Global Drugs of Abuse Analysis Controls Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Drugs of Abuse Analysis Controls Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Drugs of Abuse Analysis Controls Market Facts & Figures by Country
3.3.1 North America Drugs of Abuse Analysis Controls Sales by Country
3.3.2 North America Drugs of Abuse Analysis Controls Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Drugs of Abuse Analysis Controls Market Facts & Figures by Country
3.4.1 Europe Drugs of Abuse Analysis Controls Sales by Country
3.4.2 Europe Drugs of Abuse Analysis Controls Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drugs of Abuse Analysis Controls Market Facts & Figures by Region
3.5.1 Asia Pacific Drugs of Abuse Analysis Controls Sales by Region
3.5.2 Asia Pacific Drugs of Abuse Analysis Controls Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Drugs of Abuse Analysis Controls Market Facts & Figures by Country
3.6.1 Latin America Drugs of Abuse Analysis Controls Sales by Country
3.6.2 Latin America Drugs of Abuse Analysis Controls Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Drugs of Abuse Analysis Controls Market Facts & Figures by Country
3.7.1 Middle East and Africa Drugs of Abuse Analysis Controls Sales by Country
3.7.2 Middle East and Africa Drugs of Abuse Analysis Controls Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Drugs of Abuse Analysis Controls Historic Market Analysis by Type
4.1 Global Drugs of Abuse Analysis Controls Sales Market Share by Type (2017-2022)
4.2 Global Drugs of Abuse Analysis Controls Revenue Market Share by Type (2017-2022)
4.3 Global Drugs of Abuse Analysis Controls Price by Type (2017-2022)
5 Global Drugs of Abuse Analysis Controls Historic Market Analysis by Application
5.1 Global Drugs of Abuse Analysis Controls Sales Market Share by Application (2017-2022)
5.2 Global Drugs of Abuse Analysis Controls Revenue Market Share by Application (2017-2022)
5.3 Global Drugs of Abuse Analysis Controls Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Siemens
6.1.1 Siemens Corporation Information
6.1.2 Siemens Description and Business Overview
6.1.3 Siemens Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Siemens Drugs of Abuse Analysis Controls Product Portfolio
6.1.5 Siemens Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Abbott Drugs of Abuse Analysis Controls Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 QuidelOrtho Corporation
6.3.1 QuidelOrtho Corporation Corporation Information
6.3.2 QuidelOrtho Corporation Description and Business Overview
6.3.3 QuidelOrtho Corporation Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.3.4 QuidelOrtho Corporation Drugs of Abuse Analysis Controls Product Portfolio
6.3.5 QuidelOrtho Corporation Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Thermo Fisher Scientific Drugs of Abuse Analysis Controls Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Horiba
6.5.1 Horiba Corporation Information
6.5.2 Horiba Description and Business Overview
6.5.3 Horiba Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Horiba Drugs of Abuse Analysis Controls Product Portfolio
6.5.5 Horiba Recent Developments/Updates
6.6 Beckman Coulter
6.6.1 Beckman Coulter Corporation Information
6.6.2 Beckman Coulter Description and Business Overview
6.6.3 Beckman Coulter Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Beckman Coulter Drugs of Abuse Analysis Controls Product Portfolio
6.6.5 Beckman Coulter Recent Developments/Updates
6.7 Ortho Clinical Diagnostics
6.6.1 Ortho Clinical Diagnostics Corporation Information
6.6.2 Ortho Clinical Diagnostics Description and Business Overview
6.6.3 Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Product Portfolio
6.7.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.8 Microgenics
6.8.1 Microgenics Corporation Information
6.8.2 Microgenics Description and Business Overview
6.8.3 Microgenics Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Microgenics Drugs of Abuse Analysis Controls Product Portfolio
6.8.5 Microgenics Recent Developments/Updates
6.9 MedTest DX
6.9.1 MedTest DX Corporation Information
6.9.2 MedTest DX Description and Business Overview
6.9.3 MedTest DX Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.9.4 MedTest DX Drugs of Abuse Analysis Controls Product Portfolio
6.9.5 MedTest DX Recent Developments/Updates
6.10 Carolina Liquid Chemistries
6.10.1 Carolina Liquid Chemistries Corporation Information
6.10.2 Carolina Liquid Chemistries Description and Business Overview
6.10.3 Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Product Portfolio
6.10.5 Carolina Liquid Chemistries Recent Developments/Updates
6.11 Cerilliant
6.11.1 Cerilliant Corporation Information
6.11.2 Cerilliant Drugs of Abuse Analysis Controls Description and Business Overview
6.11.3 Cerilliant Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Cerilliant Drugs of Abuse Analysis Controls Product Portfolio
6.11.5 Cerilliant Recent Developments/Updates
6.12 American Bio Medica Corp
6.12.1 American Bio Medica Corp Corporation Information
6.12.2 American Bio Medica Corp Drugs of Abuse Analysis Controls Description and Business Overview
6.12.3 American Bio Medica Corp Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.12.4 American Bio Medica Corp Drugs of Abuse Analysis Controls Product Portfolio
6.12.5 American Bio Medica Corp Recent Developments/Updates
6.13 Clarity Diagnostics LLC
6.13.1 Clarity Diagnostics LLC Corporation Information
6.13.2 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Description and Business Overview
6.13.3 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Product Portfolio
6.13.5 Clarity Diagnostics LLC Recent Developments/Updates
6.14 Diatron
6.14.1 Diatron Corporation Information
6.14.2 Diatron Drugs of Abuse Analysis Controls Description and Business Overview
6.14.3 Diatron Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Diatron Drugs of Abuse Analysis Controls Product Portfolio
6.14.5 Diatron Recent Developments/Updates
6.15 Kova International
6.15.1 Kova International Corporation Information
6.15.2 Kova International Drugs of Abuse Analysis Controls Description and Business Overview
6.15.3 Kova International Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Kova International Drugs of Abuse Analysis Controls Product Portfolio
6.15.5 Kova International Recent Developments/Updates
6.16 Lin-Zhi International Inc
6.16.1 Lin-Zhi International Inc Corporation Information
6.16.2 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Description and Business Overview
6.16.3 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Product Portfolio
6.16.5 Lin-Zhi International Inc Recent Developments/Updates
6.17 JAS Diagnostics
6.17.1 JAS Diagnostics Corporation Information
6.17.2 JAS Diagnostics Drugs of Abuse Analysis Controls Description and Business Overview
6.17.3 JAS Diagnostics Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.17.4 JAS Diagnostics Drugs of Abuse Analysis Controls Product Portfolio
6.17.5 JAS Diagnostics Recent Developments/Updates
6.18 Quasar Instruments
6.18.1 Quasar Instruments Corporation Information
6.18.2 Quasar Instruments Drugs of Abuse Analysis Controls Description and Business Overview
6.18.3 Quasar Instruments Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Quasar Instruments Drugs of Abuse Analysis Controls Product Portfolio
6.18.5 Quasar Instruments Recent Developments/Updates
6.19 BTNX
6.19.1 BTNX Corporation Information
6.19.2 BTNX Drugs of Abuse Analysis Controls Description and Business Overview
6.19.3 BTNX Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.19.4 BTNX Drugs of Abuse Analysis Controls Product Portfolio
6.19.5 BTNX Recent Developments/Updates
6.20 Bio-Rad Laboratories
6.20.1 Bio-Rad Laboratories Corporation Information
6.20.2 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Description and Business Overview
6.20.3 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Product Portfolio
6.20.5 Bio-Rad Laboratories Recent Developments/Updates
7 Drugs of Abuse Analysis Controls Manufacturing Cost Analysis
7.1 Drugs of Abuse Analysis Controls Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drugs of Abuse Analysis Controls
7.4 Drugs of Abuse Analysis Controls Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drugs of Abuse Analysis Controls Distributors List
8.3 Drugs of Abuse Analysis Controls Customers
9 Drugs of Abuse Analysis Controls Market Dynamics
9.1 Drugs of Abuse Analysis Controls Industry Trends
9.2 Drugs of Abuse Analysis Controls Market Drivers
9.3 Drugs of Abuse Analysis Controls Market Challenges
9.4 Drugs of Abuse Analysis Controls Market Restraints
10 Global Market Forecast
10.1 Drugs of Abuse Analysis Controls Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drugs of Abuse Analysis Controls by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Drugs of Abuse Analysis Controls by Type (2023-2028)
10.2 Drugs of Abuse Analysis Controls Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drugs of Abuse Analysis Controls by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Drugs of Abuse Analysis Controls by Application (2023-2028)
10.3 Drugs of Abuse Analysis Controls Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drugs of Abuse Analysis Controls by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Drugs of Abuse Analysis Controls by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Drugs of Abuse Analysis Controls Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Drugs of Abuse Analysis Controls Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Drugs of Abuse Analysis Controls Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Drugs of Abuse Analysis Controls Market Competitive Situation by Manufacturers in 2021
Table 5. Global Drugs of Abuse Analysis Controls Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Drugs of Abuse Analysis Controls Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Drugs of Abuse Analysis Controls Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Drugs of Abuse Analysis Controls Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Drugs of Abuse Analysis Controls Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Drugs of Abuse Analysis Controls Manufacturing Sites and Area Served
Table 11. Manufacturers Drugs of Abuse Analysis Controls Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drugs of Abuse Analysis Controls by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs of Abuse Analysis Controls as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drugs of Abuse Analysis Controls Sales by Region (2017-2022) & (K Units)
Table 16. Global Drugs of Abuse Analysis Controls Sales Market Share by Region (2017-2022)
Table 17. Global Drugs of Abuse Analysis Controls Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Drugs of Abuse Analysis Controls Revenue Market Share by Region (2017-2022)
Table 19. North America Drugs of Abuse Analysis Controls Sales by Country (2017-2022) & (K Units)
Table 20. North America Drugs of Abuse Analysis Controls Sales Market Share by Country (2017-2022)
Table 21. North America Drugs of Abuse Analysis Controls Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Drugs of Abuse Analysis Controls Revenue Market Share by Country (2017-2022)
Table 23. Europe Drugs of Abuse Analysis Controls Sales by Country (2017-2022) & (K Units)
Table 24. Europe Drugs of Abuse Analysis Controls Sales Market Share by Country (2017-2022)
Table 25. Europe Drugs of Abuse Analysis Controls Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Drugs of Abuse Analysis Controls Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Drugs of Abuse Analysis Controls Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Drugs of Abuse Analysis Controls Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Drugs of Abuse Analysis Controls Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Drugs of Abuse Analysis Controls Revenue Market Share by Region (2017-2022)
Table 31. Latin America Drugs of Abuse Analysis Controls Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Drugs of Abuse Analysis Controls Sales Market Share by Country (2017-2022)
Table 33. Latin America Drugs of Abuse Analysis Controls Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Drugs of Abuse Analysis Controls Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Drugs of Abuse Analysis Controls Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Drugs of Abuse Analysis Controls Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Drugs of Abuse Analysis Controls Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Drugs of Abuse Analysis Controls Revenue Market Share by Country (2017-2022)
Table 39. Global Drugs of Abuse Analysis Controls Sales by Type (2017-2022) & (K Units)
Table 40. Global Drugs of Abuse Analysis Controls Sales Market Share by Type (2017-2022)
Table 41. Global Drugs of Abuse Analysis Controls Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Drugs of Abuse Analysis Controls Revenue Share by Type (2017-2022)
Table 43. Global Drugs of Abuse Analysis Controls Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Drugs of Abuse Analysis Controls Sales (K Units) by Application (2017-2022)
Table 45. Global Drugs of Abuse Analysis Controls Sales Market Share by Application (2017-2022)
Table 46. Global Drugs of Abuse Analysis Controls Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Drugs of Abuse Analysis Controls Revenue Share by Application (2017-2022)
Table 48. Global Drugs of Abuse Analysis Controls Price by Application (2017-2022) & (US$/Unit)
Table 49. Siemens Corporation Information
Table 50. Siemens Description and Business Overview
Table 51. Siemens Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Siemens Drugs of Abuse Analysis Controls Product
Table 53. Siemens Recent Developments/Updates
Table 54. Abbott Corporation Information
Table 55. Abbott Description and Business Overview
Table 56. Abbott Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Abbott Drugs of Abuse Analysis Controls Product
Table 58. Abbott Recent Developments/Updates
Table 59. QuidelOrtho Corporation Corporation Information
Table 60. QuidelOrtho Corporation Description and Business Overview
Table 61. QuidelOrtho Corporation Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. QuidelOrtho Corporation Drugs of Abuse Analysis Controls Product
Table 63. QuidelOrtho Corporation Recent Developments/Updates
Table 64. Thermo Fisher Scientific Corporation Information
Table 65. Thermo Fisher Scientific Description and Business Overview
Table 66. Thermo Fisher Scientific Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Thermo Fisher Scientific Drugs of Abuse Analysis Controls Product
Table 68. Thermo Fisher Scientific Recent Developments/Updates
Table 69. Horiba Corporation Information
Table 70. Horiba Description and Business Overview
Table 71. Horiba Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Horiba Drugs of Abuse Analysis Controls Product
Table 73. Horiba Recent Developments/Updates
Table 74. Beckman Coulter Corporation Information
Table 75. Beckman Coulter Description and Business Overview
Table 76. Beckman Coulter Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Beckman Coulter Drugs of Abuse Analysis Controls Product
Table 78. Beckman Coulter Recent Developments/Updates
Table 79. Ortho Clinical Diagnostics Corporation Information
Table 80. Ortho Clinical Diagnostics Description and Business Overview
Table 81. Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Product
Table 83. Ortho Clinical Diagnostics Recent Developments/Updates
Table 84. Microgenics Corporation Information
Table 85. Microgenics Description and Business Overview
Table 86. Microgenics Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Microgenics Drugs of Abuse Analysis Controls Product
Table 88. Microgenics Recent Developments/Updates
Table 89. MedTest DX Corporation Information
Table 90. MedTest DX Description and Business Overview
Table 91. MedTest DX Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. MedTest DX Drugs of Abuse Analysis Controls Product
Table 93. MedTest DX Recent Developments/Updates
Table 94. Carolina Liquid Chemistries Corporation Information
Table 95. Carolina Liquid Chemistries Description and Business Overview
Table 96. Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Product
Table 98. Carolina Liquid Chemistries Recent Developments/Updates
Table 99. Cerilliant Corporation Information
Table 100. Cerilliant Description and Business Overview
Table 101. Cerilliant Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Cerilliant Drugs of Abuse Analysis Controls Product
Table 103. Cerilliant Recent Developments/Updates
Table 104. American Bio Medica Corp Corporation Information
Table 105. American Bio Medica Corp Description and Business Overview
Table 106. American Bio Medica Corp Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. American Bio Medica Corp Drugs of Abuse Analysis Controls Product
Table 108. American Bio Medica Corp Recent Developments/Updates
Table 109. Clarity Diagnostics LLC Corporation Information
Table 110. Clarity Diagnostics LLC Description and Business Overview
Table 111. Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Product
Table 113. Clarity Diagnostics LLC Recent Developments/Updates
Table 114. Diatron Corporation Information
Table 115. Diatron Description and Business Overview
Table 116. Diatron Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Diatron Drugs of Abuse Analysis Controls Product
Table 118. Diatron Recent Developments/Updates
Table 119. Kova International Corporation Information
Table 120. Kova International Description and Business Overview
Table 121. Kova International Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Kova International Drugs of Abuse Analysis Controls Product
Table 123. Kova International Recent Developments/Updates
Table 124. Lin-Zhi International Inc Corporation Information
Table 125. Lin-Zhi International Inc Description and Business Overview
Table 126. Lin-Zhi International Inc Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Lin-Zhi International Inc Drugs of Abuse Analysis Controls Product
Table 128. Lin-Zhi International Inc Recent Developments/Updates
Table 129. JAS Diagnostics Corporation Information
Table 130. JAS Diagnostics Description and Business Overview
Table 131. JAS Diagnostics Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. JAS Diagnostics Drugs of Abuse Analysis Controls Product
Table 133. JAS Diagnostics Recent Developments/Updates
Table 134. Quasar Instruments Corporation Information
Table 135. Quasar Instruments Description and Business Overview
Table 136. Quasar Instruments Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Quasar Instruments Drugs of Abuse Analysis Controls Product
Table 138. Quasar Instruments Recent Developments/Updates
Table 139. BTNX Corporation Information
Table 140. BTNX Description and Business Overview
Table 141. BTNX Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. BTNX Drugs of Abuse Analysis Controls Product
Table 143. BTNX Recent Developments/Updates
Table 144. Bio-Rad Laboratories Corporation Information
Table 145. Bio-Rad Laboratories Description and Business Overview
Table 146. Bio-Rad Laboratories Drugs of Abuse Analysis Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Bio-Rad Laboratories Drugs of Abuse Analysis Controls Product
Table 148. Bio-Rad Laboratories Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Drugs of Abuse Analysis Controls Distributors List
Table 152. Drugs of Abuse Analysis Controls Customers List
Table 153. Drugs of Abuse Analysis Controls Market Trends
Table 154. Drugs of Abuse Analysis Controls Market Drivers
Table 155. Drugs of Abuse Analysis Controls Market Challenges
Table 156. Drugs of Abuse Analysis Controls Market Restraints
Table 157. Global Drugs of Abuse Analysis Controls Sales Forecast by Type (2023-2028) & (K Units)
Table 158. Global Drugs of Abuse Analysis Controls Sales Market Share Forecast by Type (2023-2028)
Table 159. Global Drugs of Abuse Analysis Controls Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 160. Global Drugs of Abuse Analysis Controls Revenue Market Share Forecast by Type (2023-2028)
Table 161. Global Drugs of Abuse Analysis Controls Sales Forecast by Application (2023-2028) & (K Units)
Table 162. Global Drugs of Abuse Analysis Controls Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Drugs of Abuse Analysis Controls Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Drugs of Abuse Analysis Controls Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Drugs of Abuse Analysis Controls Sales Forecast by Region (2023-2028) & (K Units)
Table 166. Global Drugs of Abuse Analysis Controls Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Drugs of Abuse Analysis Controls Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Drugs of Abuse Analysis Controls Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drugs of Abuse Analysis Controls
Figure 2. Global Drugs of Abuse Analysis Controls Market Share by Type in 2021 & 2028
Figure 3. Liquid Product Picture
Figure 4. Lyophilized Product Picture
Figure 5. Others Product Picture
Figure 6. Global Drugs of Abuse Analysis Controls Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinical
Figure 9. Diagnostic Laboratories
Figure 10. Others
Figure 11. Global Drugs of Abuse Analysis Controls Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Drugs of Abuse Analysis Controls Market Size (2017-2028) & (US$ Million)
Figure 13. Global Drugs of Abuse Analysis Controls Sales (2017-2028) & (K Units)
Figure 14. Drugs of Abuse Analysis Controls Sales Share by Manufacturers in 2021
Figure 15. Global Drugs of Abuse Analysis Controls Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Drugs of Abuse Analysis Controls Players: Market Share by Revenue in 2021
Figure 17. Drugs of Abuse Analysis Controls Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Drugs of Abuse Analysis Controls Sales Market Share by Region (2017-2022)
Figure 19. Global Drugs of Abuse Analysis Controls Sales Market Share by Region in 2021
Figure 20. Global Drugs of Abuse Analysis Controls Revenue Market Share by Region (2017-2022)
Figure 21. Global Drugs of Abuse Analysis Controls Revenue Market Share by Region in 2021
Figure 22. United States Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Colombia Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Drugs of Abuse Analysis Controls Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Drugs of Abuse Analysis Controls by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Drugs of Abuse Analysis Controls
Figure 47. Manufacturing Process Analysis of Drugs of Abuse Analysis Controls
Figure 48. Drugs of Abuse Analysis Controls Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
